The Trump Administration announced 100% tariffs on imports of pharmaceuticals to the US. What think USMB?

Zincwarrior

Diamond Member
Joined
Nov 18, 2021
Messages
41,375
Reaction score
24,831
Points
2,488
Location
Central Texas
The Trump Administration announced 100% tariffs on imports of pharmaceuticals to the US. What think USMB?



Trump administration announces new tariffs on drugmakers



The Trump administration said on Thursday that it would impose 100% tariffs on patented pharmaceuticals to force deals for lower drug prices and move manufacturing to America.

Why it matters: It is the latest example of President Trump using tariffs as leverage over corporate America.

Zoom in: The threat of tariffs, which has hung over the pharmaceutical industry for months, helped drive 13 drug companies to make "most-favored nation" pricing deals with the White House late last year.

  • It is possible that more companies will strike these voluntary pricing deals with the administration, and the new tariff announcement could be further motivation to do so to be exempted.
  • The new tariffs could also spark a wave of industry announcements about domestic manufacturing investments.
Zoom in: A senior administration official told reporters on Thursday that companies that commit to build drugs in America will be subject to a lower tariff rate of 20%.

  • Companies will be exempt from the tariff altogether if they commit to onshore manufacturing and enter into a "most-favored nation" agreement.
  • Pharmaceutical companies in Japan, South Korea, Switzerland and the European Union that do not do such deals would be subject to lower tariff rates consistent with previous trade deals.
  • The tariffs take effect in 120 days for certain large companies and 180 days for smaller companies.
Between the lines: The tariffs appear to apply to major pharma manufacturing hubs like China, Singapore and India, but they could also encourage more manufacturers with operations there to cut deals with the administration.

  • The tariffs apply only to branded drugs and their active ingredients. The White House said tariffs on lower-cost generic drugs and biosimilars would be reassessed in a year.
  • The senior administration official said they expect all the big, patented pharmaceutical companies to build in the U.S.
 
Search Assist

Most of the U.S. medicine comes from foreign sources, with a significant portion of active pharmaceutical ingredients (APIs) and finished drugs being imported, particularly from countries like China and India. In fact, about 70-80% of the U.S. generic drug supply is sourced from these two countries.

Manufacturing our own drugs is a matter of national security.

Trump is right.
 
The Trump Administration announced 100% tariffs on imports of pharmaceuticals to the US. What think USMB?



Trump administration announces new tariffs on drugmakers



The Trump administration said on Thursday that it would impose 100% tariffs on patented pharmaceuticals to force deals for lower drug prices and move manufacturing to America.

Why it matters: It is the latest example of President Trump using tariffs as leverage over corporate America.

Zoom in: The threat of tariffs, which has hung over the pharmaceutical industry for months, helped drive 13 drug companies to make "most-favored nation" pricing deals with the White House late last year.

  • It is possible that more companies will strike these voluntary pricing deals with the administration, and the new tariff announcement could be further motivation to do so to be exempted.
  • The new tariffs could also spark a wave of industry announcements about domestic manufacturing investments.
Zoom in: A senior administration official told reporters on Thursday that companies that commit to build drugs in America will be subject to a lower tariff rate of 20%.

  • Companies will be exempt from the tariff altogether if they commit to onshore manufacturing and enter into a "most-favored nation" agreement.
  • Pharmaceutical companies in Japan, South Korea, Switzerland and the European Union that do not do such deals would be subject to lower tariff rates consistent with previous trade deals.
  • The tariffs take effect in 120 days for certain large companies and 180 days for smaller companies.
Between the lines: The tariffs appear to apply to major pharma manufacturing hubs like China, Singapore and India, but they could also encourage more manufacturers with operations there to cut deals with the administration.

  • The tariffs apply only to branded drugs and their active ingredients. The White House said tariffs on lower-cost generic drugs and biosimilars would be reassessed in a year.
  • The senior administration official said they expect all the big, patented pharmaceutical companies to build in the U.S.
I’m all for it.
 
Most of the U.S. medicine comes from foreign sources, with a significant portion of active pharmaceutical ingredients (APIs) and finished drugs being imported, particularly from countries like China and India. In fact, about 70-80% of the U.S. generic drug supply is sourced from these two countries.
Trump must have seen how they make candy in India. ;)

 
Back
Top Bottom